These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2713644)

  • 1. Cholecystokinin-octapeptide antagonizes morphine analgesia in periaqueductal gray of the rat.
    Li Y; Han JS
    Brain Res; 1989 Feb; 480(1-2):105-10. PubMed ID: 2713644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antagonism of morphine analgesia and electroacupuncture analgesia by cholecystokinin octapeptide (CCK-8) administered in periaqueductal gray (PAG) of the rabbits].
    Cao W; Zhou ZF; Han JS
    Sheng Li Xue Bao; 1989 Aug; 41(4):388-94. PubMed ID: 2602948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide.
    Watkins LR; Kinscheck IB; Mayer DJ
    Brain Res; 1985 Feb; 327(1-2):169-80. PubMed ID: 3838690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in amygdala of the rat].
    Pu SF; Han JS
    Sheng Li Xue Bao; 1993 Oct; 45(5):470-8. PubMed ID: 8146670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cholecystokinin octapeptide (CCK-8) antagonized analgesia mediated by mu and kappa opioid receptors].
    Wang XH; Wang XJ; Han JS
    Sheng Li Xue Bao; 1990 Jun; 42(3):219-25. PubMed ID: 1982023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of local cholecystokinin in the tolerance induced by morphine microinjections into the periaqueductal gray of rats.
    Tortorici V; Nogueira L; Salas R; Vanegas H
    Pain; 2003 Mar; 102(1-2):9-16. PubMed ID: 12620592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine action on cholecystokinin octapeptide release from rat periaqueductal grey slices: sensitisation by naloxone.
    Rattray M; de Belleroche J
    Neuropeptides; 1987; 10(2):189-200. PubMed ID: 3683773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in nucleus accumbens of the rat via the CCK-B receptor.
    Pu SF; Zhuang HX; Han JS
    Brain Res; 1994 Sep; 657(1-2):159-64. PubMed ID: 7820614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of periaqueductal gray and nucleus raphe magnus on analgesia induced by lappaconitine, N-deacetyllappaconitine and morphine.
    Guo X; Tang XC
    Zhongguo Yao Li Xue Bao; 1990 Mar; 11(2):107-12. PubMed ID: 2275382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin and its antagonist lorglumide respectively attenuate and facilitate morphine-induced inhibition of C-fiber evoked discharges of dorsal horn nociceptive neurons.
    Kellstein DE; Price DD; Mayer DJ
    Brain Res; 1991 Feb; 540(1-2):302-6. PubMed ID: 2054623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the effect of cholecystokinin (CCK) on neurons in the periaqueductal gray of the rat: immunocytochemical and in vivo and in vitro electrophysiological studies.
    Liu H; Chandler S; Beitz AJ; Shipley MT; Behbehani MM
    Brain Res; 1994 Apr; 642(1-2):83-94. PubMed ID: 8032904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of systemic morphine analgesia in humans by proglumide, a cholecystokinin antagonist.
    Price DD; von der Gruen A; Miller J; Rafii A; Price C
    Anesth Analg; 1985 Aug; 64(8):801-6. PubMed ID: 4014744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin octapeptide antagonized opioid analgesia mediated by mu- and kappa- but not delta-receptors in the spinal cord of the rat.
    Wang XJ; Wang XH; Han JS
    Brain Res; 1990 Jul; 523(1):5-10. PubMed ID: 1976419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray.
    Netto CF; Guimarães FS
    Neuropsychopharmacology; 2004 Jan; 29(1):101-7. PubMed ID: 14583742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A reinvestigation of the analgesic effects induced by stimulation of the periaqueductal gray matter in the rat. II. Differential characteristics of the analgesia induced by ventral and dorsal PAG stimulation.
    Fardin V; Oliveras JL; Besson JM
    Brain Res; 1984 Jul; 306(1-2):125-39. PubMed ID: 6466968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NMDA receptor: central role in pain inhibition in rat periaqueductal gray.
    Jacquet YF
    Eur J Pharmacol; 1988 Sep; 154(3):271-6. PubMed ID: 2853058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin antisense RNA increases the analgesic effect induced by electroacupuncture or low dose morphine: conversion of low responder rats into high responders.
    Tang NM; Dong HW; Wang XM; Tsui ZC; Han JS
    Pain; 1997 May; 71(1):71-80. PubMed ID: 9200176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of serotonin in analgesia elicited by morphine in the periaqueductal gray matter (PAG).
    Schul R; Frenk H
    Brain Res; 1991 Jul; 553(2):353-7. PubMed ID: 1681985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance to morphine microinjections in the periaqueductal gray (PAG) induces tolerance to systemic, but not intrathecal morphine.
    Siuciak JA; Advokat C
    Brain Res; 1987 Oct; 424(2):311-9. PubMed ID: 3676830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatment.
    Kellstein DE; Mayer DJ
    Brain Res; 1990 May; 516(2):263-70. PubMed ID: 2364292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.